Volume | 29,710 |
|
|||||
News | - | ||||||
Day High | 40.73 | Low High |
|||||
Day Low | 40.36 |
Etf Name | Etf Symbol | Market | Stock Type |
---|---|---|---|
SPDR S&P Pharmaceuticals | XPH | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
40.42 | 40.36 | 40.73 | 40.61 |
Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
246 | 29,710 | 40.60 | 1,206,215 | - | 34.6704 - 45.62 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
09:30:47 | 1 | 40.7304 | USD |
SPDR S&P Pharmaceuticals Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
219.73M | 5.40M | - | 3.54M | -5.01M | -0.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News SPDR S&P Pharmaceuticals
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
XPH Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 40.31 | 41.22 | 40.2203 | 40.61 | 18,137 | 0.42 | 1.04% |
1 Month | 41.08 | 41.70 | 39.82 | 40.88 | 27,965 | -0.35 | -0.85% |
3 Months | 42.27 | 43.41 | 38.88 | 41.16 | 31,870 | -1.54 | -3.64% |
6 Months | 38.09 | 45.62 | 37.71 | 41.73 | 42,745 | 2.64 | 6.93% |
1 Year | 40.88 | 45.62 | 34.6704 | 40.88 | 41,329 | -0.15 | -0.37% |
3 Years | 50.61 | 53.82 | 34.6704 | 43.57 | 55,049 | -9.88 | -19.52% |
5 Years | 37.81 | 56.32 | 30.30 | 43.24 | 66,417 | 2.92 | 7.72% |
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI). |